Most ACPA‐positive RA patients are positive for anti–cyclic citrullinated peptide (anti‐CCP) antibodies, a hallmark that is used to classify RA patients according to the 2010 American College of Rheumatology (ACR)/European League Against Rheumatism classification criteria 1. This evidence concerns the gene PRTN3 and rheumatoid arthritis.